Merck & Co., Inc.
$112.83
▲
0.21%
2026-04-22 10:12:13
www.merck.com
NYQ: MRK
Explore Merck & Co., Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$278.33 B
Current Price
$112.83
52W High / Low
$125.14 / $73.31
Stock P/E
15.49
Book Value
$21.26
Dividend Yield
2.9%
ROCE
20.37%
ROE
36.88%
Face Value
—
EPS
$7.28
Exp Qtr EPS
—
Sector
Healthcare
Industry
Drug Manufacturers - General
Employees
73,000
Beta
0.28
Debt / Equity
95.96
Current Ratio
1.54
Quick Ratio
1.3
Forward P/E
12.4
Price / Sales
4.62
Enterprise Value
$336.22 B
EV / EBITDA
11.55
EV / Revenue
5.17
Rating
Buy
Target Price
$129.26
EPS Forecast (FY)
—
Pros
- Healthy return on equity.
- Efficient use of capital employed.
- Short-term liquidity looks comfortable.
- Strong operating margin profile.
- Net margin remains healthy.
- Valuation is not stretched on P/E basis.
- Meaningful dividend yield is available.
Cons
- Some data points may be missing or delayed because the source is not an official exchange feed.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Nasus Pharma Ltd. | $2.86 | — | $19.29 M | — | -172.62% | 2637.84% | $9.99 / $1.98 | $0.31 |
| 2. | Bristol-Myers Squibb Company | $59.38 | 17.16 | $121.36 B | 4.26% | 20.6% | 40.44% | $62.89 / $42.52 | $9.07 |
| 3. | AstraZeneca PLC | $196.47 | 30 | $305.64 B | 1.58% | 15.97% | 22.84% | $15,730 / $9,651 | $31.38 |
| 4. | Eli Lilly and Company | $921 | 40.12 | $868.52 B | 0.75% | 38.44% | 1.01% | $1,133.95 / $623.78 | $29.66 |
| 5. | Amgen Inc. | $346.69 | 24.37 | $187.08 B | 2.84% | 13.95% | 1.06% | $391.29 / $261.43 | $16.07 |
| 6. | MIRA Pharmaceuticals, Inc. | $1.12 | — | $47.06 M | — | -100.98% | -1.66% | $2.45 / $0.83 | $0.25 |
| 7. | Organon & Co. | $9.26 | 12.89 | $2.41 B | 0.86% | 11.7% | 30.56% | $13.24 / $5.69 | $2.89 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 16.4 B | 17.28 B | 15.81 B | 15.53 B | 15.62 B | — |
| Operating Profit | 4.07 B | 6.55 B | 5.55 B | 5.94 B | 4.35 B | — |
| Net Profit | 2.96 B | 5.79 B | 4.43 B | 5.08 B | 3.74 B | — |
| EPS in Rs | 1.2 | 2.34 | 1.79 | 2.06 | 1.52 | — |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 65.01 B | 64.17 B | 60.12 B | 59.28 B |
| Operating Profit | 22.11 B | 20.22 B | 2.95 B | 18.28 B |
| Net Profit | 18.25 B | 17.12 B | 365 M | 14.52 B |
| EPS in Rs | 7.39 | 6.93 | 0.15 | 5.88 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 136.87 B | 117.11 B | 106.67 B | 109.16 B |
| Total Liabilities | 84.2 B | 70.73 B | 69.04 B | 63.1 B |
| Equity | 52.61 B | 46.31 B | 37.58 B | 45.99 B |
| Current Assets | 43.52 B | 38.78 B | 32.17 B | 35.72 B |
| Current Liabilities | 28.33 B | 28.42 B | 25.69 B | 24.24 B |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 16.47 B | 21.47 B | 13.01 B | 19.09 B |
| Investing CF | -13.74 B | -7.73 B | -14.08 B | -4.96 B |
| Financing CF | -1.92 B | -7.03 B | -4.81 B | -9.12 B |
| Free CF | 12.36 B | 18.1 B | 9.14 B | 14.71 B |
| Capex | -4.11 B | -3.37 B | -3.86 B | -4.39 B |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | 6.74% | 1.4% | — | — |
| Earnings Growth % | 4589.59% | -97.49% | — | — |
| Profit Margin % | 26.68% | 0.61% | 24.49% | — |
| Operating Margin % | 31.51% | 4.91% | 30.84% | — |
| Gross Margin % | 76.32% | 73.17% | 70.63% | — |
| EBITDA Margin % | 40.06% | 11.49% | 35.95% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
| Ex Date | Dividend |
|---|---|
| 2026-03-16 | $0.85 |
| 2025-12-15 | $0.85 |
| 2025-09-15 | $0.81 |
| 2025-06-16 | $0.81 |
| 2025-03-17 | $0.81 |
Stock Splits
| Date | Split |
|---|---|
| 2021-06-03 | 1:1.048 |